Terms: = Ovarian cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1 AND Treatment
42 results:
1. Essential role of PLD2 in hypoxia-induced stemness and therapy resistance in ovarian tumors.
Muñoz-Galván S; Verdugo-Sivianes EM; Santos-Pereira JM; Estevez-García P; Carnero A
J Exp Clin Cancer Res; 2024 Feb; 43(1):57. PubMed ID: 38403587
[TBL] [Abstract] [Full Text] [Related]
2. Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
Casagrande N; Borghese C; Corona G; Aldinucci D; Altaf M; Sulaiman AAA; Isab AA; Ahmad S; Peedikakkal AMP
J Biol Inorg Chem; 2023 Dec; 28(8):751-766. PubMed ID: 37955736
[TBL] [Abstract] [Full Text] [Related]
3. Mechanisms of carboplatin- and paclitaxel-dependent induction of premature senescence and pro-cancerogenic conversion of normal peritoneal mesothelium and fibroblasts.
Rutecki S; Pakuła-Iwańska M; Leśniewska-Bocianowska A; Matuszewska J; Rychlewski D; Uruski P; Stryczyński Ł; Naumowicz E; Szubert S; Tykarski A; Mikuła-Pietrasik J; Książek K
J Pathol; 2024 Feb; 262(2):198-211. PubMed ID: 37941520
[TBL] [Abstract] [Full Text] [Related]
4.
Chen B; Jiang K; Wang H; Miao L; Lin X; Chen Q; Jing L; Lu X
Front Biosci (Landmark Ed); 2023 Sep; 28(9):220. PubMed ID: 37796700
[TBL] [Abstract] [Full Text] [Related]
5. Targeting Inhibition of Notch 1 Can Promote mTOR Signaling Pathway in Tumor-Related Macrophage to Regulate the Development of ovarian cancer.
Guo C; Mo J; Liu X; Chen Y; Liang L; Li H; Yang L
Altern Ther Health Med; 2023 Nov; 29(8):364-369. PubMed ID: 37632963
[TBL] [Abstract] [Full Text] [Related]
6. CD109 Promotes Drug Resistance in A2780 ovarian cancer Cells by Regulating the STAT3-notch1 Signaling Axis.
Kim JS; Shin MJ; Lee SY; Kim DK; Choi KU; Suh DS; Kim D; Kim JH
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373457
[TBL] [Abstract] [Full Text] [Related]
7. A
Jiang W; Ouyang X; Jiang C; Yin L; Yao Q; Pei X; Ji Z; Li M; Song S; Yang W; Huang S; Yang H; Shan B
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982170
[TBL] [Abstract] [Full Text] [Related]
8. Histone methyltransferase SETD1A interacts with notch and promotes notch transactivation to augment ovarian cancer development.
Chai H; Pan C; Zhang M; Huo H; Shan H; Wu J
BMC Cancer; 2023 Jan; 23(1):96. PubMed ID: 36707804
[TBL] [Abstract] [Full Text] [Related]
9. RHBDL2 promotes the proliferation, migration, and invasion of pancreatic cancer by stabilizing the N1ICD via the OTUD7B and activating the Notch signaling pathway.
Chen S; Cai K; Zheng D; Liu Y; Li L; He Z; Sun C; Yu C
Cell Death Dis; 2022 Nov; 13(11):945. PubMed ID: 36351890
[TBL] [Abstract] [Full Text] [Related]
10. Single-Cell RNA Sequencing Reveals the Tissue Architecture in Human High-Grade Serous ovarian cancer.
Xu J; Fang Y; Chen K; Li S; Tang S; Ren Y; Cen Y; Fei W; Zhang B; Shen Y; Lu W
Clin Cancer Res; 2022 Aug; 28(16):3590-3602. PubMed ID: 35675036
[TBL] [Abstract] [Full Text] [Related]
11. Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).
Sa JK; Kim J; Kang S; Kim SW; Song T; Shim SH; Choi MC; No JH; Song JY; Kim D; Kim YM; Kim JH; Lee JW
Int J Cancer; 2022 Oct; 151(7):1086-1097. PubMed ID: 35666535
[TBL] [Abstract] [Full Text] [Related]
12. Overexpression of BMP9 promotes ovarian cancer progression via notch1 signaling.
Yang L; Bai Y; Zhang C; Du J; Cheng Y; Wang Q; Zhang B; Yang Y
Neoplasma; 2021 Nov; 68(6):1190-1200. PubMed ID: 34533030
[TBL] [Abstract] [Full Text] [Related]
13. Chemokine CCL20 promotes the paclitaxel resistance of CD44
Chen M; Su J; Feng C; Liu Y; Zhao L; Tian Y
Mol Med Rep; 2021 Sep; 24(3):. PubMed ID: 34278466
[TBL] [Abstract] [Full Text] [Related]
14. Theasaponin E
Li B; Tong T; Ren N; Rankin GO; Rojanasakul Y; Tu Y; Chen YC
Molecules; 2021 Mar; 26(6):. PubMed ID: 33802884
[TBL] [Abstract] [Full Text] [Related]
15. The role of microRNA in cisplatin resistance or sensitivity.
Wang S; Li MY; Liu Y; Vlantis AC; Chan JY; Xue L; Hu BG; Yang S; Chen MX; Zhou S; Guo W; Zeng X; Qiu S; van Hasselt CA; Tong MC; Chen GG
Expert Opin Ther Targets; 2020 Sep; 24(9):885-897. PubMed ID: 32559147
[TBL] [Abstract] [Full Text] [Related]
16. notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial ovarian cancer cells.
Qian XQ; Tang SS; Shen YM; Chen LL; Cheng XD; Wan XY
Int J Med Sci; 2020; 17(9):1215-1223. PubMed ID: 32547317
[No Abstract] [Full Text] [Related]
17. Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers.
Bateman NW; Teng PN; Hope E; Hood BL; Oliver J; Ao W; Zhou M; Wang G; Tommarello D; Wilson K; Litzy T; Conrads KA; Hamilton CA; Darcy KM; Casablanca Y; Maxwell GL; Bae-Jump V; Conrads TP
Cancer Med; 2020 Feb; 9(3):1092-1103. PubMed ID: 31808620
[TBL] [Abstract] [Full Text] [Related]
18. Resveratrol induces cell death through ROS‑dependent downregulation of notch1/PTEN/Akt signaling in ovarian cancer cells.
Kim TH; Park JH; Woo JS
Mol Med Rep; 2019 Apr; 19(4):3353-3360. PubMed ID: 30816513
[TBL] [Abstract] [Full Text] [Related]
19. miR-22-Notch Signaling Pathway Is Involved in the Regulation of the Apoptosis and Autophagy in Human ovarian cancer Cells.
Li Y; Gu Y; Tang N; Liu Y; Zhao Z
Biol Pharm Bull; 2018; 41(8):1237-1242. PubMed ID: 30068873
[TBL] [Abstract] [Full Text] [Related]
20. MAGEA1 interacts with FBXW7 and regulates ubiquitin ligase-mediated turnover of NICD1 in breast and ovarian cancer cells.
Zhao J; Wang Y; Mu C; Xu Y; Sang J
Oncogene; 2017 Aug; 36(35):5023-5034. PubMed ID: 28459460
[TBL] [Abstract] [Full Text] [Related]
[Next]
